Transforming growth factor β3 for the prevention of vocal fold scarring

Laryngoscope

Volumn 122, Issue 3, 2012, Pages 583-589

  Ohno, Satoshi ^a   Hirano, Shigeru ^a   Kanemaru, Shin Ichi ^a   Kitani, Yoshiharu ^a   Kojima, Tsuyoshi ^a   Ishikawa, Seiji ^a   Mizuta, Masanobu ^a   Tateya, Ichiro ^a   Nakamura, Tatsuo ^b   Ito, Juichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

collagen; elastin; extracellular matrix; hyaluronic acid; Level of Evidence: 1b.; scar prevention; Transforming growth factor 3; vocal fold scarring; wound healing

Indexed keywords

COLLAGEN; ELASTIN; HYALURONIC ACID; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL DOG; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; GRANULATION TISSUE; HISTOLOGY; LAMINA PROPRIA; LARYNGOSCOPY; LARYNX DISORDER; LARYNX INJURY; NONHUMAN; PHONATION; PHONATION THRESHOLD PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCAR; VOCAL CORD; VOCAL CORD SCAR;

ANIMALS; CICATRIX; DISEASE MODELS, ANIMAL; DOGS; FOLLOW-UP STUDIES; INJECTIONS; PROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA3; TREATMENT OUTCOME; VOCAL CORDS; VOICE QUALITY; WOUND HEALING;

EID: 84862811904     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22389     Document Type: Article

References (29)

1. Rousseau B, Hirano S, Scheidt TD, et al. Characterization of vocal fold scarring in a canine model. Laryngoscope 2003; 113: 620-627. (Pubitemid 36406908)
2. Hirano S, Bless DM, Nagai H, et al. Growth factor therapy for vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 2004; 113: 777-785. (Pubitemid 39362222)
3. Kishimoto Y, Hirano S, Kitani Y, et al. Chronic vocal fold scar restoration with hepatocyte growth factor hydrogel. Laryngoscope 2010; 120: 108-113.
4. Suehiro A, Hirano S, Kishimoto Y, Rousseau B, Nakamura T, Ito J,. Treatment of acute vocal fold scar with local injection of basic fibroblast growth factor: a canine study. Acta Otolaryngol 2010; 130: 844-850.
5. Ohno S, Hirano S, Kanemaru S, et al. Implantation of an atelocollagen sponge with autologous bone marrow-derived mesenchymal stromal cells for treatment of vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 2011; 120: 401-408.
6. Sataloff RT, Spiegel JR, Heuer RJ, et al. Laryngeal mini-microflap: a new technique and reassessment of the microflap saga. J Voice 1995; 9: 198-204.
7. Campagnolo AM, Tsuji DH, Sennes LU, Imamura R, Saldiva PH,. Histologic study of acute vocal fold wound healing after corticosteroid injection in a rabbit model. Ann Otol Rhinol Laryngol 2010; 119: 133-139.
8. Coleman JR Jr., Smith S, Reinisch L, et al. Histomorphometric and laryngeal videostroboscopic analysis of the effects of corticosteroids on microflap healing in the dog larynx. Ann Otol Rhinol Laryngol 1999; 108: 119-127. (Pubitemid 29086768)
9. Schacke H, Docke WD, Asadullah K,. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002; 96: 23-43. (Pubitemid 35346616)
10. Garrett CG, Soto J, Riddick J, Billante CR, Reinisch L,. Effect of mitomycin-C on vocal fold healing in a canine model. Ann Otol Rhinol Laryngol 2001; 110: 25-30. (Pubitemid 32096802)
11. Bullard KM, Longaker MT, Lorenz HP,. Fetal wound healing: current biology. World J Surg 2003; 27: 54-61. (Pubitemid 36920185)
12. Cowin AJ, Holmes TM, Brosnan P, Ferguson MW,. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds. Eur J Dermatol 2001; 11: 424-431. (Pubitemid 32801338)
13. Massague J, Cheifetz S, Boyd FT, Andres JL,. TGF-beta receptors and TGF-beta binding proteoglycans: recent progress in identifying their functional properties. Ann N Y Acad Sci 1990; 593: 59-72. (Pubitemid 20285224)
14. Roberts AB, Sporn MB,. The transforming growth factor-betas. In:, Sporn MB, Roberts AB, editors. Peptide Growth Factors and Their Receptors. Handbook of Experimental Pharmacology. Heidelberg: Springer-Verlag; 1990: 419-472.
15. De Crescenzo G, Hinck CS, Shu Z, et al. Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor. J Mol Biol 2006; 355: 47-62. (Pubitemid 41774138)
16. Whitby DJ, Ferguson MW,. Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 1991; 147: 207-215.
17. Shah M, Foreman DM, Ferguson MW,. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995; 108 (Pt 3): 985-1002.
18. Ferguson MW, O'Kane S,. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004; 359: 839-850. (Pubitemid 38673751)
19. Ferguson MW, Duncan J, Bond J, et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet 2009; 373: 1264-1274.
20. Ohno S, Hirano S, Kanemaru S, et al. Prevention of buccal mucosa scarring with transforming growth factor β3. Laryngoscope 2011; 121: 1404-1409.
21. Ohno T, Hirano S, Kanemaru S, et al. Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 2007; 116: 762-769. (Pubitemid 47587489)
22. Abramoff MD, Magelhaes PJ, Ram SJ,. Image processing with ImageJ. Biophotonics Int 2004; 11: 36-42.
23. Rousseau B, Sohn J, Montequin DW, Tateya I, Bless DM,. Functional outcomes of reduced hyaluronan in acute vocal fold scar. Ann Otol Rhinol Laryngol 2004; 113: 767-776. (Pubitemid 39362221)
24. Murata H, Zhou L, Ochoa S, Hasan A, Badiavas E, Falanga V,. TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. J Invest Dermatol 1997; 108: 258-262. (Pubitemid 27116220)
25. Kane CJ, Hebda PA, Mansbridge JN, Hanawalt PC,. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing. J Cell Physiol 1991; 148: 157-173. (Pubitemid 21910138)
26. Bandyopadhyay B, Fan J, Guan S, et al. A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol 2006; 172: 1093-1105.
27. Hosokawa R, Nonaka K, Morifuji M, Shum L, Ohishi M,. TGF-beta 3 decreases type I collagen and scarring after labioplasty. J Dent Res 2003; 82: 558-564. (Pubitemid 41756890)
28. Chan RW, Gray SD, Titze IR,. The importance of hyaluronic acid in vocal fold biomechanics. Otolaryngol Head Neck Surg 2001; 124: 607-614. (Pubitemid 33586460)
29. Croce MA, Dyne K, Boraldi F, et al. Hyaluronan affects protein and collagen synthesis by in vitro human skin fibroblasts. Tissue Cell 2001; 33: 326-331. (Pubitemid 32755104)